| Absorption |
| Blood-Brain Barrier | BBB- | 0.6011 |
| Human Intestinal Absorption | HIA+ | 0.5860 |
| Caco-2 Permeability | Caco2- | 0.8145 |
| P-glycoprotein Substrate | Non-substrate | 0.5053 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8721 |
| Non-inhibitor | 0.6944 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9117 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6919 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8414 |
| CYP450 2D6 Substrate | Non-substrate | 0.8636 |
| CYP450 3A4 Substrate | Non-substrate | 0.6428 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8302 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9238 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9379 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9127 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9369 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9538 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9826 |
| Non-inhibitor | 0.8671 |
| AMES Toxicity | Non AMES toxic | 0.6604 |
| Carcinogens | Non-carcinogens | 0.8212 |
| Fish Toxicity | Low FHMT | 0.9162 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5290 |
| Honey Bee Toxicity | High HBT | 0.6501 |
| Biodegradation | Ready biodegradable | 0.8492 |
| Acute Oral Toxicity | IV | 0.5556 |
| Carcinogenicity (Three-class) | Non-required | 0.7480 |